These final results, along with a prior report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 aid the strategy of concentrating on ACKR3 as a novel solution to modulate the opioid process, which could open up new therapeutic avenues for opioid-related Conditions. It may also https://harryh147nkf6.luwebs.com/profile